ArisGlobal Launches NavaX Translation to Eliminate Manual Translation in Global Pharmacovigilance
Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety ...
XDI brings the first federated solution for life sciences, collapsing data silos, unifying meaning, and ...
MADRID, SPAIN – February 11, 2026 – ArisGlobal, an AI-first technology company at ...
The Ukrainian pharmaceutical company modernizes regulatory operations with a centralized platform and multi-phase innovation strategy.
The latest deployment further highlights the momentum around production AI-driven NavaX implementations, and showcases the platform’s readiness for complex, character-based languages.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved